PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention
Award Notice Posted
- Solicitation number
- N01CN87006-18
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- Multiple_Contracts-See_Below
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Not on record
- Place of performance
- To Be Determined (Contractor's Facility), United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice announces the award of multiple indefinite delivery, indefinite quantity contracts by the National Cancer Institute within the Department of Health and Human Services for cGMP production of vaccines and biologicals to support the PREVENT Cancer Preclinical Drug Development Program. Up to six contracts with a total maximum value of $49,995,000 will be awarded to contractors capable of providing analytical assay development, process development, cGMP manufacturing of 1,500 vials of specified peptides, quality documentation and other services over a period of approximately 4.5 years.
Notice text
6 versions
Update #6 · Latest ·
A Multiple-Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract was awarded to each of the following organizations in support of the PREVENT Preclinical Drug Development Program under this RFP, N01CN87006-18, titled "cGMP Production of Vaccines and Biologicals for Cancer Prevention".
cGMP Pool
75N91019D00025- Advanced Bioscience Laboratories, Inc. (Rockville, MD)
75N91019D00026- International AIDS Vaccine Initiative (New York, NY)
75N91019D00027- Kindred Biosciences, Inc. (Burlingame, CA). Awarded Vendors: Multiple_Contractors- See Below. Contract Award Dollar Amount: Not to exceed $49,995,000.00. Contract Award Date: 2019-08-14.
Update #5 ·
Please see the attached Amendment 3 for RFP #N01CN87006-18, "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention".
.
Update #4 ·
Please see the attached Amendment 2 for RFP #N01CN87006-18, "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention".
.
Update #3 ·
Please see the attached Amendment 1 for RFP #N01CN87006-18, "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention".
.
Update #2 ·
Please see the attached solicitation package for RFP #N01CN87006-18, "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention".
.
Update #1 ·
Please see the attached documents related to the Presolicitation Notice for solicitation #N01CN87006-18, "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention".
.
Files
Show all 26
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity